“`html
Why Fasting Insulin and Insulin Resistance Are the First Things to Check When Semaglutide or Tirzepatide Stops Working
If you’re hitting a GLP-1 plateau with insulin resistance as the underlying driver, no increase in dose is going to fix it — because the problem isn’t the medication, it’s your metabolic environment. Thousands of patients across Texas are getting the same frustrating news from their doctor: “You’ve plateaued. Let’s increase your dose.” But that advice skips the most important diagnostic step entirely. Before you adjust anything, the answer you need is sitting in a blood draw that most providers never order.
When GLP-1 Medications Stop Working, This Is Usually Why
Semaglutide and tirzepatide work by mimicking gut hormones that regulate appetite, slow gastric emptying, and improve insulin signaling. They’re genuinely effective tools — but they work with your metabolic system, not around it. When insulin resistance is severe and unaddressed, it creates a biochemical headwind that the medication cannot fully overcome.
Here’s what happens in plain terms: insulin resistance means your cells have stopped responding normally to insulin’s signal to absorb glucose. Your pancreas compensates by pumping out more and more insulin. High circulating insulin tells your body to store fat, not burn it. GLP-1 medications improve this signaling to a degree — but if resistance is deep-rooted, the improvement is partial and eventually plateaus.
The frustrating part? Your fasting glucose and even your A1C can look perfectly fine while your insulin is running three to five times higher than optimal. Standard labs check whether glucose is controlled. They don’t check how hard your body is working to control it.
What Standard Blood Work Consistently Misses
A routine metabolic panel or diabetes screening will show you fasting glucose. A1C gives you a 90-day glucose average. Neither of these tells you what’s happening with insulin itself. This is where the gap lives — and it’s a significant one.
When a patient comes in with a semaglutide plateau or a tirzepatide plateau, the first question should be: what is the fasting insulin? That single number tells a story that glucose never could.
What Is a Fasting Insulin Test?
A fasting insulin test is exactly what it sounds like — a blood draw after at least 8 hours without eating that measures the actual level of insulin circulating in your bloodstream. Optimal fasting insulin typically falls between 2–6 µIU/mL. Many metabolic health practitioners consider anything above 10 µIU/mL a red flag. Values above 15 or 20 are common in patients who are struggling with weight despite medications, and those patients are almost never told that number.
If you’re enrolled in a physician-supervised GLP-1 weight loss program and your provider has never ordered a fasting insulin test, this is the question to ask at your next visit. Or simply come to a practice that orders it by default.
HOMA-IR: The Number That Puts It All Together
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It’s calculated using two numbers you already have: fasting insulin and fasting glucose. The formula is simple.
HOMA-IR = (Fasting Insulin × Fasting Glucose) ÷ 405
What HOMA-IR reveals about GLP-1 plateau that glucose alone can’t capture is the degree of active resistance happening right now. Here’s what the numbers mean in practice:
- Below 1.0: Excellent insulin sensitivity. Your cells are listening.
- 1.0–1.9: Normal range, some mild resistance possible.
- 2.0–2.9: Moderate insulin resistance. Weight loss will be slower and less consistent.
- 3.0 and above: Significant insulin resistance. This is almost certainly contributing to your plateau — and it needs a targeted plan, not just a higher dose.
A HOMA-IR above 3.0 in someone who has plateaued on GLP-1 medication is not a coincidence. It is the explanation. And it points to a specific set of interventions: dietary changes that reduce insulin load, targeted nutrient repletion (magnesium, B vitamins, berberine, chromium — depending on labs), and in many women, hormonal optimization that directly improves insulin receptor sensitivity.
The Hormone Connection Most Providers Skip
Insulin resistance doesn’t develop in isolation. For women between 35 and 55, the hormonal shifts of perimenopause and menopause are a major accelerant. Estrogen plays a direct role in maintaining insulin receptor sensitivity. As estrogen drops, insulin resistance often climbs — even in women who eat well and exercise consistently.
This is why so many women in this age group hit a wall on GLP-1 therapy. The medication is doing its job, but declining estrogen is working against it at the cellular level. Progesterone also matters — low progesterone drives cortisol elevation, and chronically elevated cortisol is one of the fastest ways to deepen insulin resistance.
Testosterone, often overlooked in women entirely, directly supports muscle mass — and muscle is your primary site of glucose disposal. Less muscle means more glucose stays in the bloodstream, which means more insulin is needed to deal with it. The resistance compounds.
None of this shows up on a standard metabolic panel. All of it shows up in a comprehensive lab draw from a provider who knows what questions to ask.
What the Right Labs Actually Look Like
When semaglutide stopped working or tirzepatide has stalled, a functional medicine evaluation at minimum should include:
- Fasting insulin (not just fasting glucose)
- HOMA-IR calculation
- Full thyroid panel: TSH, Free T3, Free T4, Reverse T3, TPO antibodies
- Sex hormones: estradiol, progesterone, total and free testosterone, DHEA-S, SHBG
- Cortisol (ideally morning draw)
- Nutrient markers: magnesium, zinc, ferritin, B12, vitamin D
- Lipid panel with particle size if available
- Uric acid (elevated uric acid is a marker of insulin resistance that is almost never ordered)
Each of these numbers gives a piece of the metabolic picture. Thyroid dysfunction — even subclinical hypothyroidism with a TSH in the high-normal range — slows metabolism and increases insulin resistance independently. Low vitamin D impairs insulin secretion. Low magnesium impairs insulin receptor function. These are all fixable. But only if you find them first.
When GLP-1 Stalls, the Answer Is in the Labs — Not the Dose
When GLP-1 stops working or weight comes back, the answer is often in the blood work. Made Ya Skinny takes a functional medicine approach — running the right labs, reading them correctly, and building a plan around what your body actually needs rather than just increasing the dose. Patients who come in with a weight loss stall or insulin resistance weight loss concern get a full metabolic picture, not a default dose bump. That approach produces different results.
For residents throughout Magnolia TX, Cypress, The Woodlands, Conroe, Willis, Montgomery, Tomball, and North Houston — and for patients across Texas through telehealth — this level of functional medicine weight loss in Texas is what separates a real answer from a temporary fix.
Frequently Asked Questions
FAQ
Q: Can insulin resistance cause a GLP-1 plateau even if my A1C and fasting glucose are normal?
Yes — absolutely. Normal glucose numbers tell you that your body is successfully controlling blood sugar. They don’t tell you how hard it’s working to do that. Fasting insulin and HOMA-IR measure the effort, not just the result. Many patients with significant insulin resistance have A1C values in the completely normal range.
Q: What is a good HOMA-IR score for someone trying to lose weight on semaglutide or tirzepatide?
Most functional medicine clinicians target a HOMA-IR below 1.5 for optimal GLP-1 response. Scores above 2.0 begin to blunt weight loss results. Above 3.0, insulin resistance is likely a primary contributor to your plateau and requires a targeted intervention plan, not just a medication adjustment.
Q: Why don’t regular doctors order fasting insulin tests?
Standard practice guidelines for weight management and diabetes screening focus on glucose and A1C because those are the markers used to diagnose prediabetes and diabetes. Fasting insulin is not included in standard screening panels — so most providers simply don’t order it unless they’re specifically looking for it. A functional medicine approach orders it as a baseline metabolic marker, not an afterthought.
Q: Can hormones like estrogen and testosterone affect how well GLP-1 medications work?
Yes, directly. Estrogen supports insulin receptor sensitivity in women. When estrogen declines in perimenopause or menopause, insulin resistance typically increases — which can reduce the effectiveness of GLP-1 therapy. Testosterone in both men and women supports muscle mass, which is the primary site where the body disposes of glucose. Low testosterone contributes to insulin resistance by reducing muscle and increasing adipose tissue.
Q: Where can I get a functional medicine weight loss evaluation near Magnolia TX?
Made Ya Skinny in Magnolia, TX offers comprehensive metabolic lab evaluation paired with physician-supervised GLP-1 weight loss programs. The practice serves Magnolia, Cypress, The Woodlands, Conroe, and surrounding North Houston communities, and offers telehealth consultations for patients across Texas and multiple states.
Ready to Find Out What’s Actually Holding You Back?
If semaglutide or tirzepatide has stopped delivering results, you don’t need a higher dose — you need a better picture. The answer is in your labs. Made Ya Skinny runs the complete metabolic evaluation, identifies the exact mechanism behind your plateau, and builds a plan that works with your body rather than around it.
Stop guessing. Book your $17 visit and get the answers that standard blood work never gives you.
“`